Gout in African Americans

Eswar Krishnan1

  • 1Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif.

Insights

African Americans have a lower risk of developing gout and hyperuricemia compared to Caucasians, even after accounting for common risk factors. This finding challenges previous assumptions about gout prevalence in different ethnic groups.

Area of Science:

  • Epidemiology
  • Cardiovascular Health
  • Rheumatology

Background:

  • Gout risk factors are more prevalent in African Americans than Caucasians.
  • Previous studies suggest higher gout incidence in African Americans.

Purpose of the Study:

  • To compare the risk for incident gout between African American and Caucasian men.
  • To investigate ethnic disparities in gout incidence.

Main Methods:

  • Analysis of gout incidence in 11,559 Caucasian and 931 African American men (aged 35-57) from the Multiple Risk Factor Intervention Trial.
  • Seven-year observation period with Cox regression models to adjust for confounding factors like BMI, hypertension, diabetes, and kidney disease.

Main Results:

  • African Americans had a 14% lower prevalence of hyperuricemia at baseline.
  • After adjusting for risk factors, African American ethnicity was associated with a lower hazard ratio for gout (0.78) and hyperuricemia (0.88).
  • Ethnic disparities were most pronounced in individuals without other gout risk factors.

Conclusions:

  • African American ethnicity is linked to a significantly lower risk of gout and hyperuricemia compared to Caucasian ethnicity, after controlling for risk factor prevalence.
  • Findings indicate a need to re-evaluate ethnic disparities in gout epidemiology.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33